 In Iran, the cost of diabetes medication is not affordable for most people living below the poverty line. The cost of insulin alone can be prohibitive for many, making it difficult for them to access life-saving treatment. This article was authored by Leila Zariay, Payam Paymani, Najma Moradi, and others.